NO953560L - Genetiske suppressorelementer assosiert med sensitivitet overfor kjemoterapeutiske medikamenter - Google Patents

Genetiske suppressorelementer assosiert med sensitivitet overfor kjemoterapeutiske medikamenter

Info

Publication number
NO953560L
NO953560L NO953560A NO953560A NO953560L NO 953560 L NO953560 L NO 953560L NO 953560 A NO953560 A NO 953560A NO 953560 A NO953560 A NO 953560A NO 953560 L NO953560 L NO 953560L
Authority
NO
Norway
Prior art keywords
sensitivity
chemotherapeutic drugs
elements associated
genetic suppressor
suppressor elements
Prior art date
Application number
NO953560A
Other languages
English (en)
Other versions
NO953560D0 (no
Inventor
Igor B Roninson
Andrei Gudkov
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of NO953560D0 publication Critical patent/NO953560D0/no
Publication of NO953560L publication Critical patent/NO953560L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/44—Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO953560A 1993-03-09 1995-09-08 Genetiske suppressorelementer assosiert med sensitivitet overfor kjemoterapeutiske medikamenter NO953560L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3308693A 1993-03-09 1993-03-09
PCT/US1994/002519 WO1994020618A1 (en) 1993-03-09 1994-03-08 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs

Publications (2)

Publication Number Publication Date
NO953560D0 NO953560D0 (no) 1995-09-08
NO953560L true NO953560L (no) 1995-11-02

Family

ID=21868485

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953560A NO953560L (no) 1993-03-09 1995-09-08 Genetiske suppressorelementer assosiert med sensitivitet overfor kjemoterapeutiske medikamenter

Country Status (9)

Country Link
EP (1) EP0694068B1 (no)
JP (1) JPH08507919A (no)
KR (1) KR100267837B1 (no)
AT (1) ATE232557T1 (no)
CA (1) CA2157770A1 (no)
DE (1) DE69432120T2 (no)
NO (1) NO953560L (no)
WO (1) WO1994020618A1 (no)
ZA (1) ZA941637B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753432A (en) * 1990-10-19 1998-05-19 Board Of Trustees Of The University Of Illinois Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
CA2180426A1 (en) * 1994-01-05 1995-07-13 The Board Of Trustees Of The University Of Illinois Association of kinesin with sensitivity to chemotherapeutic drugs
US6001632A (en) * 1996-05-15 1999-12-14 Incyte Pharmaceuticals, Inc. Human protein disulfide isomerase
US5798249A (en) * 1996-05-15 1998-08-25 Incyte Pharmaceuticals, Inc. Human protein disulfide isomerase
DE69831598D1 (de) * 1997-12-19 2005-10-20 Hk Pharmaceuticals Inc Nicht-bakterielles klonierungssystem zur verabreichung und expression von nukleinsäuren
DE69933856D1 (de) 1998-02-13 2006-12-14 Koester Hubert Verwendung von ribozymen zur bestimmung der funktion von genen
WO1999053098A1 (en) * 1998-04-09 1999-10-21 Iconix Pharmaceuticals Inc. Methods for identifying genetic determinants associated with modulation of test compound activity
US6342356B1 (en) 1999-03-12 2002-01-29 Gpc Biotech, Inc. Methods and regents for identifying synthetic genetic elements
AU2135301A (en) * 1999-12-02 2001-06-12 Signalgene Inc. Preparation of sequence libraries from non-denatured rna and kits therefor
AU2001287273A1 (en) * 2000-03-24 2001-10-08 Maxygen, Inc. Methods for modulating cellular and organismal phenotypes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217889A (en) * 1990-10-19 1993-06-08 Roninson Igor B Methods and applications for efficient genetic suppressor elements

Also Published As

Publication number Publication date
JPH08507919A (ja) 1996-08-27
WO1994020618A1 (en) 1994-09-15
EP0694068B1 (en) 2003-02-12
ZA941637B (en) 1995-02-22
NO953560D0 (no) 1995-09-08
EP0694068A1 (en) 1996-01-31
CA2157770A1 (en) 1994-09-15
DE69432120D1 (de) 2003-03-20
KR100267837B1 (ko) 2001-03-02
KR960701202A (ko) 1996-02-24
ATE232557T1 (de) 2003-02-15
DE69432120T2 (de) 2003-12-11

Similar Documents

Publication Publication Date Title
US4282233B1 (en) Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
DK458480A (da) Dna, recombinant plasmid og mikroorganisme indeholdende dette samt fremgangsmaader til fremstilling deraf
DK0728143T3 (da) Onkoprotein-proteinkinase
DE3879338D1 (de) Kapazitive messvorrichtung des gasgehaltes.
TR200001023T2 (tr) Alfa-aril-N-Alkilnitronlar ve onları içeren farmasötik kompozisyonlar.
DE3871122D1 (de) Ballistische materialien.
NO954722L (no) Peptid inhibitorer med urokinase reseptoraktivitet
FI823013L (fi) Ny lipidfraktion, dess framstaellning samt densamma innehaollande farmaceutiska blandningar
NO953560D0 (no) Genetiske suppressorelementer assosiert med sensitivitet overfor kjemoterapeutiske medikamenter
WO1995022612A3 (en) Genes and genetic elements associated with sensitivity to platinum-based drugs
DK634289D0 (da) Gen og genstruktur, der koder for en aminotransferase, samt mikroorganismer, der udtrykker genet
FI850225L (fi) Radiografisk apparat foer fotografering av hela kaekpartiet.
FI892359A7 (fi) Transformering av bacillus thuringiensis.
Lawson et al. Biochemical genetics and systematics of garter snakes of the Thamnophis elegans-couchii-ordinoides complex
FR2710074B1 (fr) Gène GRB3-3, ses variants et leurs utilisations.
NO902923L (no) Lysfoelsom elektrostatisk master og anvendelse av denne.
DE59001686D1 (de) Schutzbrille gegen gase.
DK151119C (da) Gasfoelerarrangement med foroeget sensivitet
NO161684C (no) Endoproteinase-lyste f or utvinning av enzymet, samt anvendelse av enzymet til sekvensbestemmelse av proteiner og peptider.
DE69837808D1 (de) pRb2/p130 PEPTIDINHIBITOREN DER cdk2 KINASEAKTIVITÄT
NO893033D0 (no) Kullelektrode med gasstett, temperaturbestandig beskyttelsesklokke.
NO895336L (no) Bipolar, flytende elektrostatisk fremkaller og fremgangsmaate for fremstilling av denne.
DK538386A (da) Streptomycin-sensitivt gen, plasmidvektor indeholdende dette samt mikroorganisme indeholdende vektoren
FI860147A7 (fi) Plastroerskropp av termoplastiskt material, ansluten till en taetningsdel av termoplastisk elastomer, samt anpassningsdel foer anslutning till en dylik plastroerskropp.
NO880099L (no) Beskyttelseskrage for karbonanoder.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application